Clinical trial
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Diabetic Peripheral Neuropathy
NCT05507697 is registered in ClinicalTrials.gov with Wuhan Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Diabetic Peripheral Neuropathy
- Lead sponsor
- Wuhan Central Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- May 19, 2022
- Completion date
- May 31, 2024
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic peripheral neuropathy type 2